Last reviewed · How we verify

NCT04929756

Eye Movement Rehabilitation in Low Vision Patients

Status unknown Last updated 6 May 2023
What this trial tests

trial testing Visual Feedback in Low Vision in 106 participants. Status unknown.

Timeline
4 September 2020
Primary endpoint
1 May 2023
31 January 2024

Quick facts

Lead sponsorNortheastern University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment106
Start date4 September 2020
Primary completion1 May 2023
Estimated completion31 January 2024
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Northeastern University

Who can join

Adults 14 to 99, any sex, with Low Vision or Age Related Macular Degeneration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Approximately 217 million people worldwide currently suffer from low vision, which impacts a broad range of activities of daily living and is associated with depression and increased mortality. Over half of the patients presenting for low vision services have eye disease that affects the fovea and surrounding macula and leads to central vision loss (CVL). People with CVL are forced to use eccentric vision as a substitute for their impaired fovea, however eye movement control and visual function is impaired with eccentric vision. Recent evidence and preliminary results from the investigators show that rehabilitation methods can help improve oculomotor control and this can lead to improved functional outcomes. The investigators have developed new feedback-based training methods that aim to improve eccentric vision use by patients with CVL. In a series of studies, the investigators examine rehabilitation of fixation control, smooth pursuit eye movements that track moving objects and saccadic eye movements that abruptly change the point of regard. The investigators examine how visual feedback, scotoma awareness methods and hand-eye coordination can improve eccentric vision use. Improvements in oculomotor control are quantified with eye tracking methods and associated changes in visual function are quantified with acuity, contrast sensitivity and reading performance. The proposed research therefore develops and translates state-of-the-art methods in basic science to clinical applications. Accomplishing the proposed aims will provide new and improved methods for rehabilitation strategies for visual impairment. The ultimate goal of this proposal is to maximize the residual visual function of people with low vision and to help them to live independently, thereby improving quality of life and minimizing the economic and social burden of visual impairment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Visual Feedback

Trials testing the same drug.

Other recruiting trials for Low Vision

Currently open trials in the same condition.

Other Northeastern University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04929756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing